date,title,source
Oct-19-18,Does The Viveve Medical Inc (NASDAQ:VIVE) Share Price Tend To Follow The Market?,Simply Wall St.
Nov-01-18,Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results,GlobeNewswire
Nov-08-18,Viveve to Present at Stifel 2018 Healthcare Conference,GlobeNewswire
Nov-08-18,Viveve Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-15-18,Viveve Named One of North Americas 500 Fastest Growing Companies by Deloitte,GlobeNewswire
Nov-16-18,9 Colorado companies make Deloittes list of fastest-growing tech companies,American City Business Journals
Nov-21-18,"New Research Coverage Highlights Chuy's, Viveve Medical, ClearSign Combustion, WhiteHorse Finance, Crinetics Pharmaceuticals, and Boston Omaha  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-26-18,VIVE: Short-Term Headwinds Result in Lowered Guidance. Clinical Progress Sets Up Several Upcoming Milestones,Zacks Small Cap Research
Nov-29-18,Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders,GlobeNewswire
Dec-06-18,Viveve Announces Pricing of Public Offering of Shares of Common Stock,GlobeNewswire
Dec-06-18,Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study,GlobeNewswire
Dec-06-18,Viveve Announces Proposed Public Offering of Shares of Common Stock,GlobeNewswire
Dec-11-18,Viveve Announces Closing of Public Offering of Shares of Common Stock,GlobeNewswire
Dec-20-18,Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment,GlobeNewswire
Dec-24-18,VIVE: 12-Month SUI Feasibility Study Data Further Supports Compelling Efficacy Signal,Zacks Small Cap Research
Jan-03-19,Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence,GlobeNewswire
Jan-16-19,"Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update",GlobeNewswire
Mar-05-19,Viveve to Present at Cowen and Company 39th Annual Health Care Conference,ACCESSWIRE
Mar-07-19,"Viveve to Host Conference Call to Discuss Fourth Quarter and Year-end 2018 Financial Results and Corporate Update on March 14, 2019",ACCESSWIRE
Mar-11-19,Viveve Completes Enrollment in VIVEVE II Trial,ACCESSWIRE
Mar-14-19,Viveve Reports Fourth Quarter and Full Year 2018 Financial Results,ACCESSWIRE
Mar-14-19,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",Benzinga
Mar-18-19,Edited Transcript of VIVE earnings conference call or presentation 14-Mar-19 9:00pm GMT,Thomson Reuters StreetEvents
Mar-19-19,Edited Transcript of VIVE earnings conference call or presentation 14-Mar-19 9:00pm GMT,Thomson Reuters StreetEvents
Mar-20-19,"VIVE: Warning Letter Headwinds Persist, Although Dissipating. 2019 Guidance Implies Much-Improved Operating Loss",Zacks Small Cap Research
Apr-11-19,Viveve Announces CE Mark Clearance for its Next Generation 2.0 Platform in the European Union,ACCESSWIRE
Apr-12-19,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",Benzinga
Apr-30-19,Penny Stocks to Buy Using Technical Analysis for May 2019,Investopedia
May-02-19,"Viveve to Host Conference Call to Discuss First Quarter 2019 Financial and Operating Results on May 9, 2019",ACCESSWIRE
May-06-19,Penny Stocks to Buy Using Technical Analysis for May 2019,Investopedia
May-09-19,Viveve Reports First Quarter 2019 Financial and Operating Results,ACCESSWIRE
May-10-19,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-15-19,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-16-19,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-17-19,Penny Stocks to Buy Using Technical Analysis for May 2019,Investopedia
May-20-19,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-24-19,VIVE: Q1 Results: Restructuring Dramatically Improves Op Loss. $20M Sales Guidance Intact. SUI Data Read-Out This Summer,Zacks Small Cap Research
Jun-11-19,Viveve to Present at Raymond James Life Sciences and MedTech Conference,ACCESSWIRE
Jun-13-19,Edited Transcript of VIVE earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
